Benfotiamine - A New Tool In Preventing Diabetic Complications?

Benfotiamine made headlines globally in 2003 when researchers released information about a study that was conducted at The Einstein College of Medicine in New York. The bottom line of this study was that a substance of the allithiamine group of the naturally occurring thiamine-derived compounds had positive effects on neuropathy, retinopathy and nephropathy and heart/circulatory problems in diabetics.

Benfotiamine research has suggested that there are beneficial effects for diabetics and non-diabetics also. These benefits include sciatica, vascular health, general nerve health, lower blood pressure, grant cellular protection, anti-aging, fibromyalgia, prevention of lactic acidosis, and treatment for Alzheimer's disease. Any condition that is the result of a thiamine deficiency will also respond quite well to benfotiamine. Of course, any bodily function that is improved by a therapeutic level of thiamine will certainly be enhanced by benfotiamine, since benfotiamine is perhaps the most effective form of thiamine.

Benfotiamine, a derivative of thiamine (vitamin B1), was an invention of Japanese scientists and there is a U.S. patent on benfotiamine that was entered by the Japanese back in 1962. Japanese benfotiamine is considered the purest source of bulk benfotiamine and is favored by manufacturers globally who insist on the highest quality in their benfotiamine product.

The safety of benfotiamine use has been proven over 12 years of use in Europe for the treatment and prevention of diabetic complications among others. The original Japanese patent on benfotiamine gave information that it is even less toxic than common vitamin B1 (thiamine hydrochloride usually). Orally ingested vitamin B1 has a long history of use as an oral supplement without reported adverse effects. Due to its therapeutic action in some frequently observed clinical syndromes, thiamine hydrochloride has been advised and used over a long period of time. There are no reports of adverse effects of oral thiamine, even at dosages of several hundred milligrams a day (SCOGS, 1978; DHEW, 1979; Marks, 1989).

Benfotiamine has a very good safety record. To date, there has been no reports of any known, negative interactions with any medications. To the contrary, some medications actually can cause a thiamine deficiency in some people and benfotiamine could correct this serious situation.

Many researchers, medical experts, doctors, podiatrists and many medical publishers recommend benfotiamine for neuropathy, retinopathy nephropathy, heart/circulatory complications and B1 deficiencies. Any in depth study on the web will produce physicians, naturopaths, neurologists, optometrists, chiropractors, etc. who have very positive feelings about the effectiveness and potential of benfotiamine in terms of the research done to date on this important tool in the arsenal against neuropathy, retinopathy and beneficial for the heart and circulatory system. We have professional healthcare providers from all of these disciplines which shows the confidence the medical community has in the purity and bioavailability of our benfotiamine product.

Dr. David Williams, publisher of "Alternatives Newsletter", wrote an in depth article concerning benfotiamine in his May, 2004 issue. This article is an eye opener in terms of how effective benfotiamine can be for many health conditions. If possible, it would be beneficial for any interested reader to take a look at this article. For more information about this article you may contact the author below.

Dr Paul Chous is another medical professional who sees the merits of benfotiamine:

"I suspect strongly that benfotiamine will mitigate (or, hopefully, prevent) DRT in humans, but the burden of proof has not yet been met. The case for symptomatic relief of neuropathy symptoms is, of course, more tangible." http://www.emuhealthproducts.com/drchous.html

In conclusion, the consensus for benfotiamine is very positive and are worth investigating. If you or anyone you know is a diabetic, the great possibility of developing diabetic complications over time makes benfotiamine a viable tool in the arsenal for protection. If they are already experiencing complications such as neuropathy, retinopathy, and others, they will benefit from possible reduction in the progression along with pain relief in terms of peripheral neuropathy and other neuropathies.

Zach Malott is CEO of Brentwood Health International, a nutritional supplement company involved in distribution and supplying wholesale, retail and end users.

Mr. Malott is available to discuss the research as it applies to benfotiamine in the treatment and prevention of diabetic complications such as neuropathy and retinopathy.

He can be reached at:

Phone: 505.354.0526

Website: http://www.emuhealthproducts.com

Reuters
US panel urges more safety tests of diabetes drugs
Reuters - Jul 3, 2008
SILVER SPRING, Md., July 2 (Reuters) - US regulators should require more testing of the potential heart risks of new diabetes medicines, an advisory panel ...
FDA Panel: Test Diabetes Drugs For Heart Safety Wall Street Journal Blogs
FDA Panel Urges Upgrade Of Diabetes-Drug Standards Wall Street Journal
FDA Panel Calls for More Testing of Diabetes Drugs Forbes
The Associated Press - Reuters Indiaall 259 news articles

Diabetes and depression track each other
The Punch, Nigeria - 9 hours ago
By Agency reporter Depressed people may have an increased risk of Type 2 diabetes, and those with diabetes may be at increased risk for depression. ...

New Therapeutic Options For Diabetes-related Tissue Injury
Science Daily (press release) - Jul 4, 2008
ScienceDaily (July 4, 2008) — Diabetes mellitus is a metabolic disorder characterized by altered glucose tolerance and impaired lipid and carbohydrate ...

Diabetes program to help young
The Australian, Australia - Jul 5, 2008
A DIABETES treatment program eliminating the need for daily insulin injections is set to make life easier for young sufferers in Queensland. ...

Campaigner rejects any delay in child diabetes research
Radio New Zealand, New Zealand - 2 hours ago
A campaigner on child diabetes is upset at what he calls continuing delays in advancing revolutionary treatment for sufferers. The programme would allow pig ...

Coming Monday: The issue of diabetes
Meridian Star, MS - 7 hours ago
Like heart disease and cancer, diabetes is one of the deadliest diseases in America. It can cause fatal heart disease and kidney failure, and can also lead ...

Diabetes detection camp held at Mandur
Navhind Times, India - 14 hours ago
PANAJI — The Department of Preventive and Social Medicine (PSM), Goa Medical College organised a diabetes detection camp at Rural Health Training Centre, ...

Diabetes patient invents injection aid
United Press International - 15 hours ago
AUSTIN, Texas, July 5 (UPI) -- A Texas woman used a diabetes diagnosis to invent a medical aid that helps with insulin injections, a doctors says. ...

India, China to jointly work on herbal cure for diabetes
Times of India, India - Jul 4, 2008
But both countries agree on one thing for sure — the need for a herbal drug to combat diabetes. This has made scientists from India and China join hands to ...

Decoding diabetes
Brisbane Times, Australia - 21 hours ago
The Living with Diabetes Expo is Australia's only public exhibition to focus on providing answers and advice to people living with diabetes and their ...

Wind Chimes and more...

Windchimes for great gifts!

Exercise ? The Only Hope for Diabetes!